Search by Drug Name or NDC
NDC 00338-0695-04 Potassium Chloride in Sodium Chloride 300; 900 mg/100mL; mg/100mL Details
Potassium Chloride in Sodium Chloride 300; 900 mg/100mL; mg/100mL
Potassium Chloride in Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is POTASSIUM CHLORIDE; SODIUM CHLORIDE.
Product Information
NDC | 00338-0695 |
---|---|
Product ID | 0338-0695_fea3418a-bd23-4b09-a318-c56c4c0eb31a |
Associated GPIs | 79992002102030 |
GCN Sequence Number | 001199 |
GCN Sequence Number Description | potassium chloride in 0.9%NaCl IV SOLN 40 MEQ/L INTRAVEN |
HIC3 | C1D |
HIC3 Description | POTASSIUM REPLACEMENT |
GCN | 56591 |
HICL Sequence Number | 014772 |
HICL Sequence Number Description | POTASSIUM CHLORIDE IN 0.9 % SODIUM CHLORIDE |
Brand/Generic | Generic |
Proprietary Name | Potassium Chloride in Sodium Chloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Potassium Chloride and Sodium Chloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 300; 900 |
Active Ingredient Units | mg/100mL; mg/100mL |
Substance Name | POTASSIUM CHLORIDE; SODIUM CHLORIDE |
Labeler Name | Baxter Healthcare Corporation |
Pharmaceutical Class | Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA017648 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00338-0695-04 (00338069504)
NDC Package Code | 0338-0695-04 |
---|---|
Billing NDC | 00338069504 |
Package | 14 BAG in 1 CARTON (0338-0695-04) / 1000 mL in 1 BAG |
Marketing Start Date | 1979-02-02 |
NDC Exclude Flag | N |
Pricing Information | N/A |